MedPath

Ketone Esters for Optimization of Cognitive Performance in Hypoxia

Not Applicable
Conditions
Hypoxia
Ketosis
Interventions
Dietary Supplement: Taste Matched Placebo
Dietary Supplement: Ketone Ester
Other: Hypoxic exposure
Registration Number
NCT03659825
Lead Sponsor
HVMN Inc
Brief Summary

This study will investigate the effects of ketone ester drinks on cognitive performance in hypoxia.

Detailed Description

In the setting of altitude-induced hypoxia, cognitive capacity degrades and can compromise both individual and team performance. This degradation is linked to falling brain energy (ATP) levels and an increased reliance on anaerobic energy production from glucose. Ketone bodies are the evolutionary alternative substrate to glucose for brain metabolic requirements; previous studies have shown that the presence of elevated ketone bodies (ketosis) maintains brain ATP levels and reduce cerebral anaerobic glycolysis during hypoxia. Ketosis can be achieved when fasting or following a ketogenic diet; however, these approaches are impractical. Exogenous ketone ester supplementation allows for rapid (\< 30 mins) and significant elevation of blood ketone levels without the need to maintain a diet or fast.

HVMN, in collaboration with researchers at IHMC, proposes a study to investigate the effects of consuming an FDA-approved ketone ester 'food' on cognitive performance in the setting of hypoxia. For the proposed 4-arm within-subject study, participants will complete a cognitive performance test battery under the conditions of normoxia and then hypoxia following consumption of a ketone ester drink or a placebo drink (N.B for each study drink cognitive performance in both hypoxia and normoxia will be assessed in ONE visit):

VISIT A:

Arm1: Normoxia + Placebo Arm 2: Hypoxia + Placebo

VISIT B:

Arm 3: Normoxia + Ketone ester Arm 4: Hypoxia + Ketone ester

The investigators hypothesize that ketone ester supplementation will attenuate hypoxia-induced deterioration of operator cognitive performance.

Recruitment & Eligibility

Status
UNKNOWN
Sex
Male
Target Recruitment
16
Inclusion Criteria

* Pass medical examination on enrollment.

Exclusion Criteria

* Active smoker, substance abuse.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Placebo + NormoxiaTaste Matched PlaceboTaste, volume and appearance matched drink given before cognitive testing in normoxia
Placebo + HypoxiaHypoxic exposureTaste, volume and appearance matched drink given before cognitive testing in hypoxia
Ketone Ester + NormoxiaKetone EsterKetone ester drink given before cognitive testing in normoxia
Ketone Ester + HypoxiaKetone EsterKetone ester drink given before cognitive testing in hypoxia
Ketone Ester + HypoxiaHypoxic exposureKetone ester drink given before cognitive testing in hypoxia
Placebo + HypoxiaTaste Matched PlaceboTaste, volume and appearance matched drink given before cognitive testing in hypoxia
Primary Outcome Measures
NameTimeMethod
Change in Cognitive Performance- Visual AcuityMeasured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.

Cognitive performance (visual acuity) will be assessed using the RightEye testing system (https://www.righteye.com).

Change in Cognitive Performance- Eye Tracking- Smooth PursuitMeasured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.

Cognitive performance (eye tracking) will be assessed by looking for smooth pursuit (horizontal and vertical) using the RightEye testing system (https://www.righteye.com).

Change in Cognitive Performance- Eye Tracking- SaccadesMeasured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.

Cognitive performance (eye tracking) will be assessed by looking at saccade speed (horizontal and vertical) using the RightEye testing system (https://www.righteye.com).

Change in Cognitive Performance- Contrast SensitivityMeasured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.

Cognitive performance (contrast sensitivity) will be assessed using the RightEye testing system (https://www.righteye.com).

Change in Cognitive Performance- Simple Reaction TimeMeasured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.

Cognitive performance (simple reaction time) will be assessed using both the RightEye testing system (https://www.righteye.com) and the DANA testing system (http://www.danabrainvital.com).

Change in Cognitive Performance- Choice Reaction TimeMeasured 3 times (baseline [time = 0 min], during normoxia [time = 30-60 min post study drink 1] and during hypoxia [30-60 min post study drink 2]) in each of the two test visits.

Cognitive performance (choice reaction time) will be assessed using both the RightEye testing system (https://www.righteye.com) and the DANA testing system (http://www.danabrainvital.com).

Secondary Outcome Measures
NameTimeMethod
Change in blood glucose levelsMeasured 5 times at regular intervals through each of the two study visits. [time (min) = 0, 30, 75, 105, 150]

Blood glucose levels will be measured in a finger prick blood samples using a clinical grade, handheld glucose/ketone meter (Abott Diabetes Care).

Change in Grip StrengthMeasured 3 times (baseline [time = 0 min], after normoxia [60 min post study drink 1] and after hypoxia [60 min post study drink 2]) in each of the two test visits.

Grip strength will be measured using a

Change in blood ketone levelsMeasured 5 times at regular intervals through each of the two study visits. [time (min) = 0, 30, 75, 105, 150]

Blood ketone levels will be measured in a finger prick blood samples using a clinical grade, handheld glucose/ketone meter (Abott Diabetes Care).

© Copyright 2025. All Rights Reserved by MedPath